Disease Specific

Home/Disease Specific

Alzheimer’s researchers receive Chan Zuckerberg Initiative funding

A team of researchers at Washington University School of Medicine in St. Louis has been funded by the Chan Zuckerberg Initiative (CZI)to study the root causes of neurodegenerative disorders. The project at the School of Medicine will analyze genes that may help protect some patients from Alzheimer’s disease. The researchers suspect that certain variants in TREM2 and another

Historic breakthrough: WVU Rockefeller Neuroscience team first to use ultrasound to treat Alzheimer’s

World-leading brain experts at West Virginia University’s Rockefeller Neuroscience Institute are celebrating the historic breakthrough Alzheimer patients around the global have been waiting for. “For Alzheimer’s, there’s not that many treatments available despite hundreds of clinical trials over the past two decades and billions of dollars spent,” said Dr. Ali R. Rezai, a neurosurgeon at

November 20th, 2018|Categories: Alzheimer's/Dementia, Disease Specific|

Cardiovascular disease, Alzheimer’s genetically linked

Studying DNA from more than 1.5 million people, an international team of researchers — led by Washington University School of Medicine in St. Louis and the University of California, San Francisco — has identified points of DNA that increase the risk of cardiovascular disease and also heighten the risk for Alzheimer’s disease. Scientists have long

$11.5 million supports innovation in leukemia research

Extending its standing as one of the top leukemia programs in the United States, Washington University School of Medicine in St. Louis has been awarded an $11.5 million grant to further high-level investigations into leukemia and related blood cancers. The grant, from the National Institutes of Health (NIH), funds a prestigious Specialized Program in Research

SLU Scientist Tackles Debilitating Side Effects of Cancer and Pain Medications

With a pair of RO1 grants from the National Institutes of Health, pain researcher Daniela Salvemini, Ph.D., will embark on two new research projects, studying chemotherapy-induced cognitive impairment, or “chemo brain,” symptoms and unwanted side effects of opioids.  Salvemini, who is professor of pharmacology and physiology at Saint Louis University, has spent her career attempting

Siteman Cancer Center to offer newest form of proton therapy

Cancer patients in Missouri, Southern Illinois and beyond will have access to a new generation of proton therapy in early 2020. Known as pencil-beam scanning, the technology delivers extremely precise treatments of proton therapy, a type of radiation therapy used to treat cancers of the head, chest, spine and other particularly sensitive areas, as well

October 23rd, 2018|Categories: Around The State, Cancer, Disease Specific|Tags: , |